Randomized, Single-centre, Double-blind, Placebo-controlled, Phase I / IIa Study to Evaluate the Safety and Efficacy of Human Autologous Hair Follicle Dermal Sheath Cup Cells (DSCC) in Women and Men With Androgenetic Alopecia.
Phase of Trial: Phase I/II
Latest Information Update: 17 Mar 2017
At a glance
- Drugs RCH 01 (Primary)
- Indications Female pattern baldness; Male pattern baldness
- Focus Adverse reactions; First in man
- 17 Mar 2017 Results published in a RepliCel Life Sciences media release.
- 14 Mar 2017 Results published in a RepliCel Life Sciences media release.
- 06 Mar 2017 Status changed from active, no longer recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History